Inhibition of Mcl-1 Enhances the Efficacy of Tyrosine Kinase Inhibition in FLT3 Mutated AML and Synergizes with Venetoclax Targeting AML Stem Cells

被引：0
|
作者：
Carter, Bing Z. [1 ]
Tao, Wenjing [1 ]
Mak, Po Yee [1 ]
Zhang, Qi [2 ]
Wang, Xiangmeng [1 ]
Kuruvilla, Vinitha Mary [3 ]
Stewart, Carli [2 ]
Ruvolo, Vivian [1 ]
Battula, Venkata Lokesh [1 ]
Konopleva, Marina Y. [1 ]
Caenepeel, Sean [4 ]
Canon, Jude [4 ]
Hughes, Paul [4 ]
Morrow, P. K. [4 ]
Andreeff, Michael [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125725
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1267
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Targeting Mcl-1 Enhances the Activity of Tyrosine Kinase Inhibitor Gilteritinib in FLT3 Mutated AML
    Carter, Bing Z.
    Mak, Po Yee
    Ruvolo, Vivian
    Tao, Wenjing
    Hughes, Paul
    Chen, Xiaoyue
    Morrow, P. K.
    Andreeff, Michael
    BLOOD, 2020, 136
  • [2] Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-AML Cells
    Bui Thi Kim Ly
    Hoang Thanh Chi
    Yamagishi, Makoto
    Kano, Yasuhiko
    Hara, Yukihiko
    Nakano, Kazumi
    Sato, Yuko
    Watanabe, Toshiki
    PLOS ONE, 2013, 8 (06):
  • [3] Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML
    Carter, Bing Z.
    Tao, Wenjing
    Mak, Po Yee
    Ostermann, Lauren B.
    Mak, Duncan
    McGeehan, Gerard
    Ordentlich, Peter
    Andreeff, Michael
    BLOOD, 2021, 138 (17) : 1637 - 1641
  • [4] Therapeutic targeting of FLT3 mutations in AML via menin-MLL1 and FLT3 inhibition
    Dzama, Margarita M.
    Taubert, Martha C.
    Kunz, Kerstin
    Rausch, Johanna
    Chen, Chun-Wei
    Mupo, Annalisa
    Theobald, Matthias
    Kindler, Thomas
    Koche, Richard P.
    Vassiliou, George S.
    Armstrong, Scott A.
    Kuehn, Michael W.
    CANCER RESEARCH, 2019, 79 (13)
  • [5] CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-β Signaling
    Kim, Bo-Reum
    Jung, Seung-Hyun
    Han, A-Reum
    Park, Gyeongsin
    Kim, Hee-Je
    Yuan, Bin
    Battula, Venkata Lokesh
    Andreeff, Michael
    Konopleva, Marina
    Chung, Yeun-Jun
    Cho, Byung-Sik
    CANCERS, 2020, 12 (07) : 1 - 16
  • [6] Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML
    Hormi, Myriam
    Birsen, Rudy
    Belhadj, Maya
    Huynh, Tony
    Aguilar, Lilia Cantero
    Grignano, Eric
    Haddaoui, Lamya
    Guillonneau, Francois
    Mayeux, Patrick
    Hunault, Mathilde
    Tamburini, Jerome
    Kosmider, Olivier
    Fontenay, Michaela
    Bouscary, Didier
    Chapuis, Nicolas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (05) : 588 - 596
  • [7] Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis
    K Kojima
    M Konopleva
    T Tsao
    M Andreeff
    H Ishida
    Y Shiotsu
    L Jin
    Y Tabe
    H Nakakuma
    Leukemia, 2010, 24 : 33 - 43
  • [8] Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis
    Kojima, K.
    Konopleva, M.
    Tsao, T.
    Andreeff, M.
    Ishida, H.
    Shiotsu, Y.
    Jin, L.
    Tabe, Y.
    Nakakuma, H.
    LEUKEMIA, 2010, 24 (01) : 33 - 43
  • [9] Inhibition of NLRP3 enhances pro-apoptotic effects of FLT3 inhibition in AML
    Helene Sieberer
    Michela Luciano
    Diana Amend
    Constantin Blöchl
    Anna Eglseer
    Alina Steinkellner
    Sebastian Rieser
    Ancuela Andosch
    Philip Steiner
    Laura Hummer
    Peter W. Krenn
    Hieu-Hoa Dang
    Christian G. Huber
    Fritz Aberger
    Theresa Neuper
    Jutta Horejs-Hoeck
    Cell Communication and Signaling, 23 (1)
  • [10] Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition
    Dzama, Margarita M.
    Steiner, Marlene
    Rausch, Johanna
    Sasca, Daniel
    Schoenfeld, Jonas
    Kunz, Kerstin
    Taubert, Martha C.
    McGeehan, Gerard M.
    Chen, Chun-Wei
    Mupo, Annalisa
    Haehnel, Patricia
    Theobald, Matthias
    Kindler, Thomas
    Koche, Richard P.
    Vassiliou, George S.
    Armstrong, Scott A.
    Kuehn, Michael W. M.
    BLOOD, 2020, 136 (21) : 2442 - 2456
12345